These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26295176)

  • 1. Effect of nutritional counseling on low-density lipoprotein cholesterol among Thai HIV-infected adults receiving antiretroviral therapy.
    Chotivichien S; Arab L; Prasithsirikul W; Manosuthi W; Sinawat S; Detels R
    AIDS Care; 2016; 28(2):257-65. PubMed ID: 26295176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary intervention prevents dyslipidemia associated with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected individuals: a randomized trial.
    Lazzaretti RK; Kuhmmer R; Sprinz E; Polanczyk CA; Ribeiro JP
    J Am Coll Cardiol; 2012 Mar; 59(11):979-88. PubMed ID: 22402068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutritional Intervention Reduces Dyslipidemia, Fasting Glucose and Blood Pressure in People Living with HIV/AIDS in Antiretroviral Therapy: A Randomized Clinical Trial Comparing Two Nutritional Interventions.
    Aparecida Silveira E; Falco MO; Santos ASEAC; Noll M; de Oliveira C
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32998416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid profiles of Thai adult HIV-infected patients receiving protease inhibitors.
    Hiransuthikul N; Hiransuthikul P; Kanasook Y
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):69-77. PubMed ID: 17539249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant improvement in triglyceride levels after switching from ritonavir to cobicistat in suppressed HIV-1-infected subjects with dyslipidaemia.
    Echeverría P; Bonjoch A; Puig J; Ornella A; Clotet B; Negredo E
    HIV Med; 2017 Nov; 18(10):782-786. PubMed ID: 28671337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemia, Diet and Physical Exercise in Children on Treatment With Antiretroviral Medication in El Salvador: A Cross-sectional Study.
    Sonego M; Sagrado MJ; Escobar G; Lazzerini M; Rivas E; Martín-Cañavate R; Pérez de López E; Ayala S; Castaneda L; Aparicio P; Custodio E
    Pediatr Infect Dis J; 2016 Oct; 35(10):1111-6. PubMed ID: 27254031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia.
    Wohl DA; Tien HC; Busby M; Cunningham C; Macintosh B; Napravnik S; Danan E; Donovan K; Hossenipour M; Simpson RJ
    Clin Infect Dis; 2005 Nov; 41(10):1498-504. PubMed ID: 16231263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Spirulina platensis supplementation on lipid profile in HIV-infected antiretroviral naïve patients in Yaounde-Cameroon: a randomized trial study.
    Ngo-Matip ME; Pieme CA; Azabji-Kenfack M; Biapa PC; Germaine N; Heike E; Moukette BM; Emmanuel K; Philippe S; Mbofung CM; Ngogang JY
    Lipids Health Dis; 2014 Dec; 13():191. PubMed ID: 25496727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dyslipidemia and cardiovascular risk assessment in HIV-positive patients].
    Uysal S; Tuncel Başoğlu M; Boydak B; Gökengin D
    Turk Kardiyol Dern Ars; 2017 Mar; 45(2):145-152. PubMed ID: 28424436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir.
    Llibre JM; Domingo P; Palacios R; Santos J; Pérez-Elías MJ; Sánchez-de la Rosa R; Miralles C; Antela A; Moreno S;
    AIDS; 2006 Jun; 20(10):1407-14. PubMed ID: 16791015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of HIV infection and HAART on serum lipids in men.
    Riddler SA; Smit E; Cole SR; Li R; Chmiel JS; Dobs A; Palella F; Visscher B; Evans R; Kingsley LA
    JAMA; 2003 Jun; 289(22):2978-82. PubMed ID: 12799406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid profile changes in Thai HIV and tuberculosis co-infected patients receiving non-nucleoside reverse transcriptase inhibitors-based antiretroviral therapy.
    Mankhatitham W; Luaengniyomkul A; Manosuthi W
    J Med Assoc Thai; 2012 Feb; 95(2):163-9. PubMed ID: 22435244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment.
    Keiser PH; Sension MG; DeJesus E; Rodriguez A; Olliffe JF; Williams VC; Wakeford JH; Snidow JW; Shachoy-Clark AD; Fleming JW; Pakes GE; Hernandez JE;
    BMC Infect Dis; 2005 Jan; 5():2. PubMed ID: 15647105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipidemia and its association with meibomian gland dysfunction.
    Braich PS; Howard MK; Singh JS
    Int Ophthalmol; 2016 Aug; 36(4):469-76. PubMed ID: 26515235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of fenofibrate on lipid profile, endothelial dysfunction, and inflammatory markers in type 2 diabetes mellitus patients with typical and mixed dyslipidemia.
    Ghani RA; Bin Yaakob I; Wahab NA; Zainudin S; Mustafa N; Sukor N; Wan Mohamud WN; Kadir KA; Kamaruddin NA
    J Clin Lipidol; 2013; 7(5):446-53. PubMed ID: 24079286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-line antiretroviral therapy and changes in lipid levels over 3 years among HIV-infected adults in Tanzania.
    Liu E; Armstrong C; Spiegelman D; Chalamilla G; Njelekela M; Hawkins C; Hertzmark E; Li N; Aris E; Muhihi A; Semu H; Fawzi W
    Clin Infect Dis; 2013 Jun; 56(12):1820-8. PubMed ID: 23449270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia.
    Kostapanos MS; Milionis HJ; Filippatos TD; Nakou ES; Bairaktari ET; Tselepis AD; Elisaf MS
    Clin Ther; 2007 Jul; 29(7):1403-14. PubMed ID: 17825691
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.